Thermogenic Cell Capsule for Metabolic Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for visceral obesity, such as lifestyle changes and pharmacological interventions, are ineffective in reducing visceral fat and associated metabolic and inflammatory diseases, and existing therapies like gene-based and pharmaceutical approaches are costly, risky, and not easily scalable for widespread use.
Innovation Solution
Implantation of a capsule containing thermogenic cells, engineered to increase their thermogenic capacity, which are encapsulated to prevent immune rejection and controlled for duration of treatment, allowing for site-specific and systemic impact on fat metabolism.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If gene-based or pharmaceutical approaches are used to increase thermogenic adipocytes, then thermogenic capacity is improved, but cost and risk increase significantly
Solution Approach 1:
The patent uses an encapsulation system as an intermediary carrier to deliver thermogenic adipocytes to the target site. The capsule protects the cells during transplantation and controls their release, mediating between the cell preparation process and the implantation site, thereby simplifying the overall treatment protocol while maintaining therapeutic efficacy
Solution Approach 2:
The treatment is segmented into distinct components: cell isolation, encapsulation, and implantation. This segmentation allows each step to be optimized independently and facilitates standardized manufacturing protocols, reducing complexity while maintaining reliability
2Reliability
If stem cell transplantation is performed without encapsulation, then cell integration is improved, but immune rejection increases
Solution Approach 1:
The biocompatible capsule acts as an intermediary barrier between the transplanted stem cells and the host immune system. This protective interface allows cells to integrate and function while shielding them from immune recognition and rejection, resolving the contradiction between integration and immune acceptance
Solution Approach 2:
The capsule creates an inert, immunologically neutral environment around the transplanted cells. By providing a biocompatible barrier that does not trigger immune responses, the capsule protects vulnerable stem cells while they establish themselves in the host tissue
3Duration of action of stationary object
If permanent cell implantation is used, then long-term effect is improved, but controllability and reversibility are lost
Solution Approach 1:
The capsule system introduces dynamic controllability to the treatment. The degradation rate of the capsule can be engineered to match therapeutic needs, and the implant can be removed or adjusted if clinical outcomes require modification, providing adaptability while maintaining long-term effects
Solution Approach 2:
The treatment duration is controlled through the periodic degradation of the biocompatible capsule material. As the capsule degrades over a predetermined period, it releases cells in a controlled manner, providing sustained therapeutic effect while maintaining the possibility of intervention if needed
4Reliability
If personalized stem cell therapy is implemented, then treatment efficacy is improved, but cost and scalability worsen
Solution Approach 1:
The encapsulation platform provides a universal solution that can accommodate different cell types and treatment protocols. The standardized capsule design and manufacturing process enable the same system to be used across multiple patients and indications, achieving scalability while maintaining personalized treatment efficacy through cell source flexibility
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The treatment effectively reduces fat mass, decreases inflammation, and improves insulin sensitivity, offering a safe, cost-effective, and scalable solution for obesity and related metabolic diseases by exploiting natural endocrine properties of fat cells.
Implementation Method 1
thermogenic adipocytes that have many mitochondria and produce heat utilizing stored lipids. In contrast to lipogenic adipocytes, thermogenic adipocytes burn fat to produce heat instead of storing it
Implementation Method 2
thermogenesis is mediated by a family of mitochondrial uncoupling proteins (UCP1-5), which dissipate the proton gradient in mitochondria before it can be used to provide the energy for ATP synthesis
Implementation Method 3
The membrane is configured to permit the passage of nutrients and chemical messengers to and from the core
Data Source
AI summary
Described herein are methods and devices for treating a metabolic disease that involve implanting a micro-device into a tissue of a subject having a metabolic disease. The micro-device includes a plurality of thermogenic cells encapsulated in a biocompatible capsule. The capsule includes a core to accommodate the plurality of thermogenic cells and a porous immunoprotective membrane that allows for metabolic interaction between the plurality of thermogenic cells and the tissue.